Depression treatment, Neurotransmitters and mental health and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Depression treatment

Neurotransmitters and mental health

Pharmaceuticals

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Short of this, the best remaining course to take is a retraction.”

Pharmaceuticals

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Five)

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals

Mental Health Clinicians

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Five)

Stay Connected